Atlas Trials

AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery

Clinical trial NCT02065245 · COMPLETED

Trial details

NCT number
NCT02065245
Sponsor
Longeveron Inc.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Frailty
Start date
2014-03-03
Primary completion
2019-10-02
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.